Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model

Journal of Neuro-Oncology

Volumn 41, Issue 3, 1999, Pages 235-246

  Takeda, Norio ^a,b   Diksic, Mirko ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Yamagata Prefectural Central Hospital   (Japan)

Author keywords

Brain tumor; Chemotherapy; Drug delivery; Drug streaming; Intra arterial administration

Indexed keywords

ANTINEOPLASTIC AGENT; NALPHA [N (2 CHLOROETHYL) N NITROSOCARBAMOYL]SARCOSINAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BRAIN CANCER; BRAIN TOXICITY; CAROTID ARTERY; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TUMOR LEVEL; FEMALE; FLOW RATE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTORADIOGRAPHY; BRAIN; BRAIN NEOPLASMS; CARMUSTINE; CELL LINE; FEMALE; GLIOMA; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRA-ARTERIAL; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; TRITIUM;

EID: 0032895612     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006104220315     Document Type: Article

References (48)

1. Shapiro WR, Byrne TN: Chemotherapy of brain tumor -basic concepts. In: Walker MD (ed) Oncology of the Nervous System. Martinus Nijhoff, Boston, 1983, pp 66-100
2. Hochberg FH, Parker LM, Takvorian T, Canellos GP, Zervas NT: High dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg 54: 455-460, 1981
3. Djerassi I, Jung SK, Reggev A: Response of astrocytoma to high-dose methotrexate with citrovorum factor rescue. Cancer 55: 2741-2747, 1985
4. Fine HA, Aritman KH: High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience. Bone Marrow Transplant 10: 315-321, 1992
5. Levin VA, Kabra PM, Freeman-Dove MA: Pharmacokinetics of intracarotid artery C-BCNU in the squirrel monkey. J Neurosurg 48: 587-593, 1978
6. Tyler JL, Yamamoto YL, Diksic M, Theron J, Villemure JG, Worthington C, Evans AC, Feindel W: Pharmacokinetics of superselective intra-arterial and intravenous C-BCNU evaluated by PET. J Nucl Med 27: 775-778, 1986
7. Echman WW, Patlak CS, Fenstermacher JD: A critical evaluation of the principles governing the advantages of intraarterial infusion. J Pharmacokinet Biopharm 2: 257-285, 1974
8. Fenstermacher DE, Cowles AL: Theoretical limitations of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep 61: 519-526, 1977
9. Yamada K, Ushio Y, Hayakawa T, Arita N, Huang TY, Nagatani M, Yamada Y, Mogami H: Distribution of radio-labeled 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rat brain tumor: intra-arterial versus intravenous administration. Cancer Res 47: 2123-2128, 1987
10. Schuster JM, Friedman HS, Archer GE, Fuchs HE, McLendon RE, Colvin OM, Bigner DD: Intra-arterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide. Cancer Res 53: 2338-2343, 1993
11. Hodozuka A, Sako K, Nakal H, Tomabechi M, Suzuki N, Yonemasu Y: Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus intravenous infusion. J Neuro-Oncol 15: 79-86, 1993
12. Bullard DE, Bigner SH, Bigner DD: Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model. Cancer Res. 45: 5240-5245, 1985
13. Fauchon F, Davila L, Chatellier G, Fohanno D, Philippon J, Rey A, Chiras J, Poisson M, Delattre JY: Treatment of malignant gliomas with surgery, intra-arterial infusions of 1-(2-hydroxyethyl)chloroethylnitrosourea, and radiation therapy: a phase II study. Neurosurgery 27: 231-234, 1990
14. Shapiro WR, Green SB, Burger PC, Selker PRG, VanGilder JC, Robertson JT, Mealey Jr. J, Ransohoff J, Mahaley Jr. S: A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76: 772-781, 1992
15. Saris SC, Blasberg RG, Carson RE, de Vroom HL, Lutz RJ, Dedrick RL, Pettigrew K, Chang R, Doppman J, Wright DC, Herscovitch P, Oldfield EH: Intravascular streaming during carotid artery infusions. J Neurosurg 74: 763-772, 1991
16. Nagahiro S, Yamamoto YL, Diksic M, Mitsuka S, Sugimoto S, Feindel W: Neurotoxicity after intracarotid 1,3-bis(2-chloroethyl)-1-nitrosourea administration in the rat: hemodynamic changes studied by double-tracer autoradiography. Neurosurgery 29: 19-25, 1991
17. Lutz RJ, Dedrick RL, Boretos JW, Oldfield EH, Blacklock JB, Doppman JL: Mixing studies during intracarotid artery infusion in an in vitro model. J Neurosurg 64: 277-283, 1986
18. Blacklock JB, Wright DC, Dedrick RL, Blasberg RG, Lutz RJ, Doppman JL, Oldfield EH: Drug streaming during intraarterial chemotherapy. J Neurosurg 64: 284-291, 1986
19. Greensberg HS, Ensminger WD, Chandler WF, Layton PB, Junck L, Knake J, Vine AK: Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg 61: 423-429, 1984
20. Bobo H, Kapp JP, Vance R: Effect of intra-arterial cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation. J Neuro-Oncol 13: 291-299, 1992
21. Hochberg FH, Pruitt AA, Beck DO, DeBrun G, Davis K: The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma. J Neurosurg 63: 876-880, 1985
22. Mahaley Jr MS, Hipp SW, Dropcho EJ, Bertsch L, Cush S, Tirey T, Gillespie GY: Intracarotid cisplatin chemotherapy for recurrent gliomas. J Neurosurg 70: 371-378, 1989
23. Madajewicz S, Chowhan N, Iliya A, Roque C, Beaton R, Davis R, Fertman S, Meek A, Alvares O, Pampati M, Tyson G: Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors. Cancer 67: 2844-2849, 1991
24. Mortimer JE, Crowley J, Eyre H, Weiden P, Eltringham J, Struckey WJ: A phase II randomized study comparing sequential and combined intra-arterial cisplatin and radiation therapy in primary brain tumors. A Southwest Oncology Group Study. Cancer 69: 1220-1223, 1992
25. DiChiro G, Oldfield EH, Wright DC: Cerebral necrosis after radiotherapy and/or intra-arterial chemotherapy for brain tumors: PET and neuropathologic studies. AINR 8: 1083-1091, 1987
26. Bashir R, Hochberg FH, Linggood RM, Hottleman K: Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme. J Neurosurg 68: 917-919, 1988
27. Johnson DW, Parkinson D, Wolpert SM, Kasdon DL, Kwan ESK, Laucella M, Anderson ML: Intracarotid chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma. Neurosurgery 20: 577-583, 1987
28. Rogers LR, Purvis JB, Lederman RJ, Rosenbloom SA, Tomsak RL, Estes ML, Magdinec M, Medendorp SV, Boyett JM: Alternating sequential intracarotidBCNU and cis-platin in recurrent malignant glioma. Cancer 68: 15-21, 1991
29. Suami T, Kato T, Takino H, Hisamatu T: (2-Chloroethyl)-nitrosourea congeners of amino acid amides. J Med Chem 25: 829-832, 1982
30. Panasci LC, Dufour M, Chevalier L, Isabel G, Lazarus P, McQuillian A, Arbit E, Brem S, Feindel W: Utilization of HTSCA and CFV-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human gliomas compared with BCNU. Cancer Chemo Pharm 14: 156-159, 1985
31. Houchens D, Nies R, Riblets S, Finfrok M, Trigg N: Immunodeficient animals in biochemical research. In: Wu BQ, Zheng J (eds) VI Int Workshop on Immunodeficient Animals. Karger Publishing, Basel, Switzerland, 1989, pp 157-161
32. 11C-labelled BCNU and SarCNU in gliomas studied by PET. J Neuro-Oncol 10: 47-55, 1991
33. Takeda N, Diksic M, Yamamoto YL: The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy. Cancer 77: 1167-1179, 1996
34. Kurpad SN, Friedman HS, Archer GE, McLendon RE, Petros WM, Fuchs HE, Guaspari A, Bigner DD: Intra-arterial administration of melphalan for treatment of intracranial human xenografts in athymic rats. Cancer Research 55: 3803-3809, 1995
35. Blasberg RG, Kobayashi bT, Patlak CS, Shinohara M, Miyoaka M, Rice JM, Shapiro WR: Regional blood flow, capillary permeability, and glucose utilization in two brain tumor models: preliminary observations and pharmacokinetic implications. Cancer Treat Report 65 (Suppl. 2): 3-12, 1981
36. Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Shishido F, Uemura K: Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 73: 2386-2394, 1994
37. Saris SC, Blasberg RG, Carson RE, deVroom HL, Lutz R, Dedrick RL, Pettigrew K, Chang R, Doppman J, Wright DC, Herscovitch P, Oldfield EH: Intravascular streaming during carotid artery infusions. Demonstration in humans and reduction using diastole-phased pulsatile administration. J Neurosurg 74: 763-772, 1991
38. Bloor BM, Glista GG: Observations on simultaneous internal carotid artery and total cerebral blood flow measurements in man. Neurosurgery 1: 249-255, 1977
39. Uematsu S, Yang A, Preziosi TJ, Kouba R, Toung TJ: Measurement of carotid blood flow in man and its clinical application. Stroke 14: 256-266, 1983
40. Weihe WH: The laboratory rat. In: Poole T (ed) The UFAW Handbook on The Care and Management of Laboratory Animals. Longman Scientific & Technical, Essex, 1987, pp 309-330
41. 14C]antipyrine. Am J Physiol 234: H59-H66, 1978
42. Watanabe A, Tanaka R, Takeda N, Washiyama K: DNA synthesis, blood flow, and glucose utilization in experimental rat brain tumors. J Neurosurg 70: 86-91, 1989
43. Bullard DE, Saris SC, Bigner DD: Carotid artery injections in 40- to 99-g Fischer rats: Technical note and evaluation of blood flow by various injection techniques. Neurosurgery 14: 406-411, 1984
44. Watne K, Hannisdal E, Nome O, Hager B, Hirschberg H: Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumor. Neurosurgery 30: 223-227, 1992
45. Stewart DJ, Grahovac Z, Hugenholtz H, DaSilva V, Richard MT, Benoit B, Belanger G, Russel N: Feasibility study of intra-arterial vs intravenous cisplatin, BCNU, and toniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors. J Neuro-Oncol 17: 71-79, 1993
46. Shook DR, Beaudet LM, Doppman JL: Uniformity of intracarotid drug distribution with diastole-phased pulsed infusion. J Neurosurg 67: 726-731, 1987
47. Aoki S, Terada H, Kosuda S, Shitara N, Fujii H, Suzuki K, Kutsukake Y, Tanaka J, Sasaki Y, Okubo T, Shirouzu I, Machida T, Sasaki Y: Supraophthalmic chemotherapy with long tapered catheter: distribution evaluated with intra-arterial and intravenous Tc-99m. Radiology 188: 347-350, 1993
48. Li JKJ: Laminar and turbulent flow in the mammalian aorta: Reynolds number. J Theor Biol 135: 409-414, 1988